Forbes October 10, 2019
Joshua Cohen

Of the approximately 7,000 rare diseases 80% are genetic. And, more than half of rare diseases affect children.

For patients and their caregivers, one of the more frustrating aspects of rare diseases is the length of time from symptom onset to an accurate diagnosis, which averages 4.8 years.

Last month, together with several colleagues in the House, Representative Eric Swalwell of California reintroduced a bipartisan bill called Advancing Access to Precision Medicine Act. The legislation had originally been proposed in January 2018, and is aimed at promoting the use of genetic and genomic testing to improve healthcare delivery. Specifically, the bill is designed to improve patient access to genetic and genomic testing to help shorten the time to diagnosis, easing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Patient / Consumer, Precision Medicine, Provider, Technology
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce

Share This Article